OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights.

Third Quarter Financial Highlights

• Bookings:  $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024.
• Private Placements: Successfully completed an additional $0.5M private placement of common stock from an insider, providing further investment towards strategic objectives.
• Further Improved Balance Sheet: Continuing with its efforts first reported at the end of the second quarter, OneMedNet further improved its balance sheet by reducing total liabilities by an additional $1.9 million during the third quarter, with year-to-date reductions in total liabilities totaling $14.3 million.
  

Operational Highlights

• Integration of Palantir’s AI Platform: In September 2025, OneMedNet commenced a Pilot on Palantir Technologies' Artificial Intelligence Platform (AIP) to integrate with our iRWD network, which provided us insights on the platform capabilities including:
  • Faster data discovery (in minutes rather than days);
  • AI-driven de-identification for large scale orders;
  • Healthcare standards integration (e.g., SNOMED, HCPCS, ICD-10, CPT); and
  • Federated search, and Multimodal data integration.
    
• Rollout of SaaS Subscription Model: OneMedNet announced the delivery of its recurring revenue model promise through Palantir-powered RWD subscriptions, featuring Live Data Feeds and AI-Driven Conversational Search.
  
• These offerings transform static data access into dynamic, on-demand intelligence, allowing customers to harness regulatory-grade, multimodal data for real-time insights and accelerated decision-making, bolstering the Company's recurring revenue foundation.

“The combination of reduced debt, and strategic capital infusions enables us to focus on strategic opportunities to deliver long-term value to our customers, partners, and shareholders. Our continued focus on our strategy in the third quarter has resulted in a more resilient sales pipeline, larger deal sizes with a 4.5X increase in inbound demand, building steady momentum for OneMedNet.   Additionally, by utilizing Palantir's AI Platform to enhance our scalable proven platform, we are accelerating the delivery of our subscription models, enabling faster, more efficient access to high-quality real-world data for our clients,” says Aaron Green, CEO & President of OneMedNet.